TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
Tushar D. Nichakawade, Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang, Sarah R. DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian F. Konig, Sandra B. Gabelli, Evangeline Watson, Cole Sterling, Nina D. Wagner‐Johnston, Sima Rozati, Lode J. Swinnen, Ephraim J. Fuchs, Drew M. Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W. Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
Topics & Concepts
Chimeric antigen receptorAntibodyMedicineAntibody-drug conjugateCancer researchCancerT cellImmunologyCellAntigenImmunotherapyMonoclonal antibodyInternal medicineBiologyImmune systemGeneticsCAR-T cell therapy researchCutaneous lymphoproliferative disorders researchLymphoma Diagnosis and Treatment